Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a variable
clinical course and high mortality. We used data from a large national US registry of patients …

Introduction PROOF (a Prospective Observational Registry to Describe the Disease Course
and Outcomes of Idiopathic Pulmonary Fibrosis) is an ongoing, observational registry …

Background Idiopathic pulmonary fibrosis (IPF) is characterized by the accumulation of
fibrillar collagens in the alveolar space resulting in reduced pulmonary function and a high …

PURPOSE: IPF is a progressive fibrosing interstitial lung disease characterized by loss of
lung function, dyspnea and cough, and high mortality. The Idiopathic Pulmonary Fibrosis …

The peripheral blood contains disease presence and outcome relevant information, and
suggests distinct biologically defined outcome trajectories in patients with IPF. Although …

Background Our study examined whether prevalent and incident comorbidities are
increased in idiopathic pulmonary fibrosis (IPF) patients when compared to matched chronic …

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …

Idiopathic pulmonary fibrosis (IPF) is a complex, heterogeneous genetic disorder that is
associated with rare and common sequence variants in many genes (MUC5B, SFTPC …

METHODS: Subjects were included if they had a new diagnosis of definite or probable IPF
or definite or probable idiopathic fibrotic NSIP as defined by the ATS/ERS consensus …

Rationale Peripheral blood biomarkers are needed to identify and determine the extent of
idiopathic pulmonary fibrosis (IPF). Current physiologic and radiographic prognostic …